PL1965669T3 - Kompozycja zawierająca oligosacharydy jako rozpuszczalny błonnik pokarmowy do stosowania przeciw zanikowi mięśni - Google Patents

Kompozycja zawierająca oligosacharydy jako rozpuszczalny błonnik pokarmowy do stosowania przeciw zanikowi mięśni

Info

Publication number
PL1965669T3
PL1965669T3 PL06824315T PL06824315T PL1965669T3 PL 1965669 T3 PL1965669 T3 PL 1965669T3 PL 06824315 T PL06824315 T PL 06824315T PL 06824315 T PL06824315 T PL 06824315T PL 1965669 T3 PL1965669 T3 PL 1965669T3
Authority
PL
Poland
Prior art keywords
oligosaccharides
composition
muscle wasting
soluble dietary
use against
Prior art date
Application number
PL06824315T
Other languages
English (en)
Inventor
Marchel Gorselink
Helvoort Adrianus Lambertus Bertholdus Van
Robert Johan Joseph Hageman
Original Assignee
Nutricia Nv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=36028309&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=PL1965669(T3) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Nutricia Nv filed Critical Nutricia Nv
Publication of PL1965669T3 publication Critical patent/PL1965669T3/pl

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/20Milk; Whey; Colostrum
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23LFOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/20Reducing nutritive value; Dietetic products with reduced nutritive value
    • A23L33/21Addition of substantially indigestible substances, e.g. dietary fibres
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23LFOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/40Complete food formulations for specific consumer groups or specific purposes, e.g. infant formula
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/70Carbohydrates; Sugars; Derivatives thereof
    • A61K31/702Oligosaccharides, i.e. having three to five saccharide radicals attached to each other by glycosidic linkages
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/70Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/70Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A61K31/729Agar; Agarose; Agaropectin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/70Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A61K31/731Carrageenans
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/70Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A61K31/733Fructosans, e.g. inulin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/70Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A61K31/736Glucomannans or galactomannans, e.g. locust bean gum, guar gum
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00Drugs for disorders of the muscular or neuromuscular system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00Drugs for disorders of the muscular or neuromuscular system
    • A61P21/06Anabolic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/02Nutrients, e.g. vitamins, minerals
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07HSUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H3/00Compounds containing only hydrogen atoms and saccharide radicals having only carbon, hydrogen, and oxygen atoms
    • C07H3/06Oligosaccharides, i.e. having three to five saccharide radicals attached to each other by glycosidic linkages
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23VINDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2002/00Food compositions, function of food ingredients or processes for food or foodstuffs
PL06824315T 2005-12-16 2006-12-18 Kompozycja zawierająca oligosacharydy jako rozpuszczalny błonnik pokarmowy do stosowania przeciw zanikowi mięśni PL1965669T3 (pl)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP05112336 2005-12-16
PCT/NL2006/050320 WO2007069900A1 (en) 2005-12-16 2006-12-18 Use of soluble dietary fibres against muscle wasting
EP06824315A EP1965669B1 (en) 2005-12-16 2006-12-18 Composition comprising oligosaccharides as soluble dietary fibres for use against muscle wasting

Publications (1)

Publication Number Publication Date
PL1965669T3 true PL1965669T3 (pl) 2010-02-26

Family

ID=36028309

Family Applications (1)

Application Number Title Priority Date Filing Date
PL06824315T PL1965669T3 (pl) 2005-12-16 2006-12-18 Kompozycja zawierająca oligosacharydy jako rozpuszczalny błonnik pokarmowy do stosowania przeciw zanikowi mięśni

Country Status (17)

Country Link
US (2) US8143235B2 (pl)
EP (1) EP1965669B1 (pl)
JP (1) JP2009519328A (pl)
CN (2) CN102948659B (pl)
AT (1) ATE441333T1 (pl)
AU (1) AU2006325591B2 (pl)
BR (1) BRPI0619947B1 (pl)
CA (1) CA2633292C (pl)
DE (1) DE602006008985D1 (pl)
DK (1) DK1965669T3 (pl)
ES (1) ES2332149T3 (pl)
IL (1) IL192219A (pl)
NZ (1) NZ569169A (pl)
PL (1) PL1965669T3 (pl)
RU (1) RU2450815C2 (pl)
WO (1) WO2007069900A1 (pl)
ZA (1) ZA200805905B (pl)

Families Citing this family (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20080126195A1 (en) 2004-07-22 2008-05-29 Ritter Andrew J Methods and Compositions for Treating Lactose Intolerance
US8252742B2 (en) * 2004-12-30 2012-08-28 Hill's Pet Nutrition, Inc. Methods for enhancing the quality of life of a senior animal
JP4610499B2 (ja) * 2006-02-27 2011-01-12 ポーラ化成工業株式会社 食品組成物
WO2009153064A2 (en) * 2008-06-19 2009-12-23 N.V. Nutricia Liquid nutritional composition for bariatric surgery patients
WO2009157759A1 (en) 2008-06-23 2009-12-30 N.V. Nutricia Nutritional composition for improving the mammalian immune system
WO2010002242A1 (en) 2008-07-02 2010-01-07 N.V. Nutricia Nutritional composition for improving muscle function and daily activity
BRPI0915974A2 (pt) * 2008-07-18 2017-05-30 Hill´S Pet Nutrition Inc métodos para modular funções biológicas, para tratar um animal sofrendo de um distúrbio ou doença, para alterar a expressão de pelo menos um peptídeo em um mamífero, e para triar um ou mais compostos de teste para habilidade para alterar a expressão de pelo menos um gene de interesse em um mamífero
SG2014014435A (en) 2009-02-24 2014-07-30 Ritter Pharmaceuticals Inc Prebiotic formulations and methods of use
WO2010143939A1 (en) * 2009-06-09 2010-12-16 N.V. Nutricia Nutrition for improving muscle strength in elderly
EP2563372A4 (en) 2010-04-28 2013-10-02 Ritter Pharmaceuticals Inc PREBIOTIC FORMULATIONS AND METHODS OF USE
CN103476274A (zh) * 2011-04-18 2013-12-25 雀巢产品技术援助有限公司 具有α-HICA和α-酮戊二酸的营养组合物
WO2014007606A1 (en) * 2012-07-05 2014-01-09 N.V. Nutricia Product for use in the prophylactic or therapeutic treatment of a negative emotion or introvert behaviour
ES2402643B1 (es) 2012-12-24 2014-01-24 Universitat De Lleida Combinación de fibra anticolesterolémica
MY186844A (en) 2014-07-09 2021-08-25 Cadena Bio Inc Oligosaccharide compositions and methods for producing thereof
WO2016029113A1 (en) * 2014-08-22 2016-02-25 Abbott Laboratories Methods of increasing endogenous production of beta-hydroxy-beta-methylbutyrate
JP2018517677A (ja) 2015-04-23 2018-07-05 カレイド・バイオサイエンシズ・インコーポレイテッド グリカン治療剤及び治療方法
KR102548553B1 (ko) * 2016-04-14 2023-06-27 듀폰 뉴트리션 바이오사이언시즈 에이피에스 제지방 체중을 증가시키기 위한 비피더스균
CN106387923B (zh) * 2016-09-07 2019-12-20 中国农业大学 一种富含半乳甘露聚糖的可溶性膳食纤维及其制备方法
EP3357352B1 (de) 2017-02-02 2021-03-24 artgerecht GmbH Zusammensetzung mit aminosäuren
DE102017201713A1 (de) * 2017-02-02 2018-08-02 artgerecht GmbH Zusammensetzung mit Aminosäuren
AU2019376144A1 (en) * 2018-11-08 2021-05-13 Dsm Ip Assets, B.V. Methods of supporting gastrointestinal homeostasis
AU2019376668A1 (en) * 2018-11-08 2021-05-13 Dsm Ip Assets, B.V. Methods of selectively modulating gastrointestinal microbial growth
TW202108007A (zh) * 2019-05-24 2021-03-01 比利時商科舒克拉 格魯普瓦爾科迎有限公司 包含纖維及蛋白質之組合物

Family Cites Families (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5444054A (en) * 1994-04-01 1995-08-22 Abbott Labatories Method of treating ulcerative colitis
US5589468A (en) 1995-01-13 1996-12-31 Clintec Nutrition Co. Method for providing nutrition to elderly patients
US5641531A (en) * 1995-09-28 1997-06-24 Abbott Laboratories Nutritional liquid supplement beverage and method of making same
US6077828A (en) * 1996-04-25 2000-06-20 Abbott Laboratories Method for the prevention and treatment of cachexia and anorexia
ATE218065T1 (de) * 1996-08-09 2002-06-15 Mannatech Inc Zusammensetzungen auf pflanzliicher kohlenhydratbasis als nahrungsergänzungsstoffe
US5776524A (en) 1996-10-30 1998-07-07 The Iams Company Process for treating small intestine bacterial overgrowth in animals
US5817695A (en) * 1997-12-24 1998-10-06 Pellico; Michael A. Nutritional product with high fat, low carbohydrate and amino acid imbalance
DE19836339B4 (de) * 1998-08-11 2011-12-22 N.V. Nutricia Kohlenhydratmischung
GB2364642B (en) * 2000-01-07 2004-10-27 Bioenergy Inc Compositions for enhancing the immune response
US6420342B1 (en) * 2000-05-08 2002-07-16 N.V. Nutricia Nutritional preparation comprising ribose and medical use thereof
US6592863B2 (en) 2000-08-22 2003-07-15 Nestec S.A. Nutritional composition
US7431939B1 (en) 2000-09-28 2008-10-07 Mississippi State University Inhibition of systemic infections in humans and vertebrates by dietary fibers
JP2003137790A (ja) * 2001-11-01 2003-05-14 Mie Kariyou Kk β−2,1(β2→β1)結合連鎖フラクトースオリゴマーを含有するフラクトオリゴ糖を有効成分とする医薬
JP2004051942A (ja) * 2002-05-29 2004-02-19 Daicel Chem Ind Ltd 分散体及びそれを用いた成形体の製造方法
US20040087490A1 (en) 2002-09-20 2004-05-06 Troup John P. Nutritional compositions
GB0229015D0 (en) * 2002-12-12 2003-01-15 Novartis Nutrition Ag New Compound
DK1643861T3 (da) * 2003-07-15 2011-07-25 Nestec Sa Fiber- og kalorierig flydende næringssammensætning til tarmsundhed hos ældre patienter
CN1871015B (zh) * 2003-10-24 2010-06-16 努特里奇亚有限公司 免疫调节性寡糖
NZ546785A (en) * 2003-10-24 2009-07-31 Nutricia Nv Immunemodulating oligosaccharides
AU2006237738B2 (en) * 2005-04-21 2011-09-29 N.V. Nutricia Nutritional supplement for HIV patients
WO2009157759A1 (en) 2008-06-23 2009-12-30 N.V. Nutricia Nutritional composition for improving the mammalian immune system

Also Published As

Publication number Publication date
ATE441333T1 (de) 2009-09-15
IL192219A (en) 2011-08-31
NZ569169A (en) 2012-01-12
EP1965669A1 (en) 2008-09-10
CN101374426A (zh) 2009-02-25
AU2006325591B2 (en) 2012-07-12
CN102948659A (zh) 2013-03-06
CA2633292A1 (en) 2007-06-21
CA2633292C (en) 2015-04-28
JP2009519328A (ja) 2009-05-14
ZA200805905B (en) 2009-10-28
RU2450815C2 (ru) 2012-05-20
WO2007069900A1 (en) 2007-06-21
BRPI0619947A2 (pt) 2011-10-25
EP1965669B1 (en) 2009-09-02
CN101374426B (zh) 2012-11-28
CN102948659B (zh) 2014-04-23
US8143235B2 (en) 2012-03-27
US9555059B2 (en) 2017-01-31
US20090203573A1 (en) 2009-08-13
BRPI0619947B1 (pt) 2023-10-10
IL192219A0 (en) 2008-12-29
DK1965669T3 (da) 2009-10-05
US20120165243A1 (en) 2012-06-28
RU2008129102A (ru) 2010-01-27
ES2332149T3 (es) 2010-01-27
DE602006008985D1 (de) 2009-10-15
AU2006325591A1 (en) 2007-06-21

Similar Documents

Publication Publication Date Title
PL1965669T3 (pl) Kompozycja zawierająca oligosacharydy jako rozpuszczalny błonnik pokarmowy do stosowania przeciw zanikowi mięśni
PL1841332T3 (pl) Kompozycja zagęszczacza dla pacjentów z trudnością połykania
MX2009000657A (es) Composiciones y metodos para el tratamiento de mucositis.
CR20150097A (es) Composición inmunogénica
MXPA05009015A (es) Nuevos derivados de bencimidazol e imidazo-piridina y su utilizacion como medicamentos.
HK1100765A1 (en) Use of rotigotine for treating and preventing parkinson's plus syndrome
MX2009003821A (es) Compuestos de n-aril pirazol para usarse contra la diabetes.
WO2004089353A3 (en) Methods for treatment of parkinson's disease
PL2046378T3 (pl) Zastosowanie bakteryjnych polisacharydów do hamowania biofilmu
PT1965809E (pt) Composições para melhorar a saúde do intestino e o rendimento animal compreendendo beta-glucanos e alfa-fucanos
NZ624749A (en) A sulfated polysaccharide compound and the preparation and use thereof
ATE461780T1 (de) Werkzeugmaschinenkartusche
UA88956C2 (ru) Синергическая фунгицидная комбинация действующих веществ
MY159514A (en) Composition comprising 1, 3/1, 6 beta glucan for reducing weight
NZ530037A (en) Use of glycosaminoglycans for the treatment of HIV-associated nephropathy
MXPA05013016A (es) Gaboxadol para el tratamiento de la depresion y otros trastornos afectivos.
EP2082082A4 (en) MULTICOMPONENT FIBERS CONTAINING HIGH CHAIN LENGTH POLYAMIDES
MY139498A (en) Composition, process of making, and medical use of substituted 4-phenyltetrahydroisoquinolines
BRPI0506466A (pt) composição alimentìcia pobre em carboidratos e método para fabricar uma composição alimentìcia
EP0989226A3 (en) Water based fiber treatment agent
ATE518544T1 (de) Rotbusch-extrakt gegen diabetes
PT1641875E (pt) Composi??o amil?cea cati?nica l?quida e suas utiliza??es
UA97359C2 (en) Immunogenic composition
MXPA05013969A (es) Poliorganosiloxanos.
UA90656C2 (ru) Габоксадол для лечения депрессии